179 related articles for article (PubMed ID: 12704767)
1. Dynamic, contrast-enhanced perfusion MRI in mouse gliomas: correlation with histopathology.
Cha S; Johnson G; Wadghiri YZ; Jin O; Babb J; Zagzag D; Turnbull DH
Magn Reson Med; 2003 May; 49(5):848-55. PubMed ID: 12704767
[TBL] [Abstract][Full Text] [Related]
2. Perfusion MRI (dynamic susceptibility contrast imaging) with different measurement approaches for the evaluation of blood flow and blood volume in human gliomas.
Thomsen H; Steffensen E; Larsson EM
Acta Radiol; 2012 Feb; 53(1):95-101. PubMed ID: 22114021
[TBL] [Abstract][Full Text] [Related]
3. Improved T(1)-weighted dynamic contrast-enhanced MRI to probe microvascularity and heterogeneity of human glioma.
Pauliah M; Saxena V; Haris M; Husain N; Rathore RK; Gupta RK
Magn Reson Imaging; 2007 Nov; 25(9):1292-9. PubMed ID: 17490844
[TBL] [Abstract][Full Text] [Related]
4. Low-grade gliomas: do changes in rCBV measurements at longitudinal perfusion-weighted MR imaging predict malignant transformation?
Danchaivijitr N; Waldman AD; Tozer DJ; Benton CE; Brasil Caseiras G; Tofts PS; Rees JH; Jäger HR
Radiology; 2008 Apr; 247(1):170-8. PubMed ID: 18372467
[TBL] [Abstract][Full Text] [Related]
5. Correlation of relative permeability and relative cerebral blood volume in high-grade cerebral neoplasms.
Provenzale JM; York G; Moya MG; Parks L; Choma M; Kealey S; Cole P; Serajuddin H
AJR Am J Roentgenol; 2006 Oct; 187(4):1036-42. PubMed ID: 16985154
[TBL] [Abstract][Full Text] [Related]
6. [Value of relative cerebral blood volume measurement using perfusion MRI in glioma management].
Metellus P; Dutertre G; Mekkaoui C; Nanni I; Fuentes S; Ait-Ameur A; Chinot O; Dufour H; Figarella-Branger D; Cordoliani YS; Grisoli F
Neurochirurgie; 2008 Aug; 54(4):503-11. PubMed ID: 18573509
[TBL] [Abstract][Full Text] [Related]
7. Semi-automated and automated glioma grading using dynamic susceptibility-weighted contrast-enhanced perfusion MRI relative cerebral blood volume measurements.
Friedman SN; Bambrough PJ; Kotsarini C; Khandanpour N; Hoggard N
Br J Radiol; 2012 Dec; 85(1020):e1204-11. PubMed ID: 23175486
[TBL] [Abstract][Full Text] [Related]
8. Correlation of MR imaging-determined cerebral blood volume maps with histologic and angiographic determination of vascularity of gliomas.
Sugahara T; Korogi Y; Kochi M; Ikushima I; Hirai T; Okuda T; Shigematsu Y; Liang L; Ge Y; Ushio Y; Takahashi M
AJR Am J Roentgenol; 1998 Dec; 171(6):1479-86. PubMed ID: 9843274
[TBL] [Abstract][Full Text] [Related]
9. Characterization of glioma microcirculation and tissue features using intravoxel incoherent motion magnetic resonance imaging in a rat brain model.
Iima M; Reynaud O; Tsurugizawa T; Ciobanu L; Li JR; Geffroy F; Djemai B; Umehana M; Le Bihan D
Invest Radiol; 2014 Jul; 49(7):485-90. PubMed ID: 24619211
[TBL] [Abstract][Full Text] [Related]
10. MR evaluation of vessel size imaging of human gliomas: Validation by histopathology.
Kellner E; Breyer T; Gall P; Müller K; Trippel M; Staszewski O; Stein F; Saborowski O; Dyakova O; Urbach H; Kiselev VG; Mader I
J Magn Reson Imaging; 2015 Oct; 42(4):1117-25. PubMed ID: 25683112
[TBL] [Abstract][Full Text] [Related]
11. High-grade gliomas and solitary metastases: differentiation by using perfusion and proton spectroscopic MR imaging.
Law M; Cha S; Knopp EA; Johnson G; Arnett J; Litt AW
Radiology; 2002 Mar; 222(3):715-21. PubMed ID: 11867790
[TBL] [Abstract][Full Text] [Related]
12. [Correlation between dynamic contrast-enhanced MRI and expression of microvascular density in the glioma].
Yin D; Wang XY; Yan XB; Liao WH
Zhong Nan Da Xue Xue Bao Yi Xue Ban; 2005 Dec; 30(6):686-9. PubMed ID: 16708810
[TBL] [Abstract][Full Text] [Related]
13. Assesment of perfusion in glial tumors with arterial spin labeling; comparison with dynamic susceptibility contrast method.
Cebeci H; Aydin O; Ozturk-Isik E; Gumus C; Inecikli F; Bekar A; Kocaeli H; Hakyemez B
Eur J Radiol; 2014 Oct; 83(10):1914-9. PubMed ID: 25087109
[TBL] [Abstract][Full Text] [Related]
14. Quantification of blood flow in brain tumors: comparison of arterial spin labeling and dynamic susceptibility-weighted contrast-enhanced MR imaging.
Warmuth C; Gunther M; Zimmer C
Radiology; 2003 Aug; 228(2):523-32. PubMed ID: 12819338
[TBL] [Abstract][Full Text] [Related]
15. Usefulness of diffusion/perfusion-weighted MRI in rat gliomas: correlation with histopathology.
Fan G; Zang P; Jing F; Wu Z; Guo Q
Acad Radiol; 2005 May; 12(5):640-51. PubMed ID: 15866139
[TBL] [Abstract][Full Text] [Related]
16. High-resolution longitudinal assessment of flow and permeability in mouse glioma vasculature: Sequential small molecule and SPIO dynamic contrast agent MRI.
Pike MM; Stoops CN; Langford CP; Akella NS; Nabors LB; Gillespie GY
Magn Reson Med; 2009 Mar; 61(3):615-25. PubMed ID: 19235262
[TBL] [Abstract][Full Text] [Related]
17. Detection of T(2) changes in an early mouse brain tumor.
Blasiak B; Tomanek B; Abulrob A; Iqbal U; Stanimirovic D; Albaghdadi H; Foniok T; Lun X; Forsyth P; Sutherland GR
Magn Reson Imaging; 2010 Jul; 28(6):784-9. PubMed ID: 20395097
[TBL] [Abstract][Full Text] [Related]
18. Quantitative measurement of leakage volume and permeability in gliomas, meningiomas and brain metastases with dynamic contrast-enhanced MRI.
Lüdemann L; Grieger W; Wurm R; Wust P; Zimmer C
Magn Reson Imaging; 2005 Oct; 23(8):833-41. PubMed ID: 16275421
[TBL] [Abstract][Full Text] [Related]
19. Correlation between dynamic susceptibility contrast perfusion MRI and methionine metabolism in brain gliomas: preliminary results.
Sadeghi N; Salmon I; Tang BN; Denolin V; Levivier M; Wikler D; Rorive S; Balériaux D; Metens T; Goldman S
J Magn Reson Imaging; 2006 Nov; 24(5):989-94. PubMed ID: 17031832
[TBL] [Abstract][Full Text] [Related]
20. Using relative cerebral blood flow and volume to evaluate the histopathologic grade of cerebral gliomas: preliminary results.
Shin JH; Lee HK; Kwun BD; Kim JS; Kang W; Choi CG; Suh DC
AJR Am J Roentgenol; 2002 Sep; 179(3):783-9. PubMed ID: 12185064
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]